Company Overview
About Ceribell
Ceribell is a commercial-stage medical technology company that has reimagined the electroencephalogram (EEG) for the acute care setting. Its flagship product is a rapid-application, disposable EEG system with an AI algorithm called Clarity that detects electrographic seizures in real time. The platform is FDA-cleared for use across all patient ages — from pre-term neonates through adults — making it the only point-of-care EEG with that breadth of clearance. In December 2025, Ceribell received additional FDA 510(k) clearance for its AI-powered delirium monitoring solution, the first and only FDA-cleared delirium screening and monitoring device.
Business Model & Competitive Advantage
Ceribell went public on Nasdaq (CBLL) and reported full-year 2025 revenue of $89.1M, up 36% year-over-year, with Q4 2025 revenue of $24.8M (up 34% YoY). For 2026, the company guided to $111M–$115M in revenue, representing approximately 25–29% growth. In January 2026, the FDA granted Ceribell a Breakthrough Device Designation for an LVO (large vessel occlusion) stroke detection and monitoring solution, expanding its neurological monitoring pipeline beyond seizure detection into stroke and delirium.
Competitive Landscape 2025–2026
Ceribell''s competitive advantage lies in its rapid-application electrode array — which can be placed in under two minutes by bedside nursing staff — combined with its proprietary Clarity AI algorithm for continuous seizure probability scoring. The system is designed to capture nonconvulsive seizures that are invisible to standard clinical observation, a critical capability in ICUs and emergency departments where seizure burden is significantly underdiagnosed. The company''s longer-term strategy spans three horizons: penetrating seizure detection in acute care, expanding within acute care to delirium and stroke, and eventually extending into outpatient and broader neurological settings.
Key Differentiators
Market Leader
Ceribell is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Similar Brands
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Compare Ceribell with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ceribell? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ceribell Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ceribell vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →